1-(Pyridin-4-ylmethyl)imidazolidin-2-imine

ID: ALA4081815

PubChem CID: 135386336

Max Phase: Preclinical

Molecular Formula: C9H12N4

Molecular Weight: 176.22

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C1NCCN1Cc1ccncc1

Standard InChI:  InChI=1S/C9H12N4/c10-9-12-5-6-13(9)7-8-1-3-11-4-2-8/h1-4H,5-7H2,(H2,10,12)

Standard InChI Key:  GDYYNCOCTRHJIE-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 13 14  0  0  0  0  0  0  0  0999 V2000
   19.1421  -20.9168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9592  -20.9168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2136  -20.1401    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.5506  -19.6580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8919  -20.1401    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.5494  -18.8408    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.9912  -19.8887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5977  -20.4363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4244  -21.2335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0301  -21.7809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8086  -21.5297    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.9779  -20.7259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3709  -20.1820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  4  6  2  0
  3  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4081815

    ---

Associated Targets(non-human)

Chrna3 Neuronal acetylcholine receptor; alpha3/beta4 (1368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna4 Neuronal acetylcholine receptor; alpha4/beta2 (3557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 176.22Molecular Weight (Monoisotopic): 176.1062AlogP: 0.42#Rotatable Bonds: 2
Polar Surface Area: 52.01Molecular Species: BASEHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 11.88CX LogP: -0.08CX LogD: -2.50
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.69Np Likeness Score: -1.07

References

1. Wu J, Cippitelli A, Zhang Y, Debevec G, Schoch J, Ozawa A, Yu Y, Liu H, Chen W, Houghten RA, Welmaker GS, Giulianotti MA, Toll L..  (2017)  Highly Selective and Potent α4β2 nAChR Antagonist Inhibits Nicotine Self-Administration and Reinstatement in Rats.,  60  (24): [PMID:29178785] [10.1021/acs.jmedchem.7b01250]

Source